Literature DB >> 11994396

Peroxisome proliferator activated receptor gamma expression is reduced in the colonic mucosa of acromegalic patients.

Fausto Bogazzi1, Federica Ultimieri, Francesco Raggi, Aurelio Costa, Maurizio Gasperi, Elisabetta Cecconi, Franco Mosca, Luigi Bartalena, Enio Martino.   

Abstract

UNLABELLED: Acromegalic patients have an increased prevalence of colonic polyps, due to the elevated serum insulin like growth factor (IGF)-I levels. The mechanisms underlying this process are poorly understood. Peroxisome proliferator activated receptor (PPAR)gamma, a nuclear receptor that regulates adipocyte differentiation, is highly expressed in the human colonic mucosa, where it induces growth inhibition and cell differentiation. In the present study we evaluated the expression of PPARgamma in the bioptic samples of colonic mucosa from 22 patients with acromegaly (Acro) and 13 normal subjects (CONTROLS) matched for age and sex. Among Acro patients, 10 had active, untreated disease (AcroUntr), 6 were in remission after surgery (AcroRem), and 6 had active disease under treatment with somatostatin analogs (AcroSMSa). Serum GH and IGF-I (mean +/- SD) levels were as follows: AcroUntr: GH, 36 +/- 40 microg/l; IGF-I, 769 +/- 298 microg/l; AcroRem: GH, 1.0 +/- 1.3 microg/l; IGF-I, 248 +/- 96 microg/l; AcroSMSa: GH, 7.8 +/- 12 microg/l; IGF-I, 429 +/- 221 microg/l; CONTROLS: GH, 0.8 +/- 0.7 microg/l; IGF-I, 203 +/- 67 microg/l. In the CONTROLS the level of expression of PPARgamma mRNA was 15230 +/- 891 transcripts. Patients with AcroUntr had 2750 +/- 688 transcripts of PPARgamma. (p < 0.0001) vs. CONTROLS); patients AcroSMSa had 4629 +/- 1286 transcripts of PPARgamma. (p = NS vs AcroUntr, p = 0.0002 vs. CONTROLS); patients with AcroRem had 8261 +/- 2481 transcripts of PPARgamma (p = 0.008 vs. AcroUntr, p = NS vs. AcroSMSa, p = 0.007 vs. CONTROLS). A significant inverse correlation was found between serum IGF-I concentrations and the level of expression of PPARgamma (r = 0.43, p = 0.03). In conclusion, patients with active Acro have a reduced expression of PPARgamma in the colonic mucosa, which appears be related to the increased serum IGF-I levels and might lead to an increased prevalence of colonic polyps.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 11994396     DOI: 10.1210/jcem.87.5.8625

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  13 in total

Review 1.  Complications of acromegaly: thyroid and colon.

Authors:  Amit Tirosh; Ilan Shimon
Journal:  Pituitary       Date:  2017-02       Impact factor: 4.107

2.  Signal transducer and activator of transcription 5b promotes mucosal tolerance in pediatric Crohn's disease and murine colitis.

Authors:  Xiaonan Han; Bankole Osuntokun; Nancy Benight; Kimberly Loesch; Stuart J Frank; Lee A Denson
Journal:  Am J Pathol       Date:  2006-12       Impact factor: 4.307

Review 3.  PPARgamma as a new therapeutic target in inflammatory bowel diseases.

Authors:  L Dubuquoy; C Rousseaux; X Thuru; L Peyrin-Biroulet; O Romano; P Chavatte; M Chamaillard; P Desreumaux
Journal:  Gut       Date:  2006-09       Impact factor: 23.059

4.  Functional characterization of peroxisome proliferator-activated receptor-β/δ expression in colon cancer.

Authors:  Jennifer E Foreman; Wen-Chi L Chang; Prajakta S Palkar; Bokai Zhu; Michael G Borland; Jennie L Williams; Lance R Kramer; Margie L Clapper; Frank J Gonzalez; Jeffrey M Peters
Journal:  Mol Carcinog       Date:  2011-03-11       Impact factor: 4.784

5.  Insulin-like growth factor and epidermal growth factor treatment: new approaches to protecting steatotic livers against ischemia-reperfusion injury.

Authors:  Araní Casillas-Ramírez; Amine Zaouali; Susagna Padrissa-Altés; Ismail Ben Mosbah; Anna Pertosa; Izabel Alfany-Fernández; Maria Bintanel-Morcillo; Carme Xaus; Antoni Rimola; Juan Rodés; Joan Roselló-Catafau; Carmen Peralta
Journal:  Endocrinology       Date:  2009-03-12       Impact factor: 4.736

6.  Peroxisome proliferator-activated receptor gamma ligands inhibit cell growth and induce apoptosis in human liver cancer BEL-7402 cells.

Authors:  Ming-Yi Li; Hua Deng; Jia-Ming Zhao; Dong Dai; Xiao-Yu Tan
Journal:  World J Gastroenterol       Date:  2003-08       Impact factor: 5.742

7.  Adrenal morpho-functional alterations in patients with acromegaly.

Authors:  C Scaroni; R Selice; S Benedini; E De Menis; M Arosio; C Ronchi; M Gasperi; L Manetti; G Arnaldi; B Polenta; M Boscaro; N Albiger; E Martino; F Mantero
Journal:  J Endocrinol Invest       Date:  2008-07       Impact factor: 4.256

8.  Colonic polyps of acromegalic patients are not associated with mutations of the peroxisome proliferator activated receptor gamma gene.

Authors:  F Bogazzi; F Ultimieri; F Raggi; D Russo; S Brogioni; C Cosci; M Gasperi; A Costa; P Viacava; F Mosca; L Bartalena; E Martino
Journal:  J Endocrinol Invest       Date:  2003-11       Impact factor: 4.256

9.  High prevalence of hyperplastic colonic polyps in acromegalic subjects.

Authors:  A Martino; G Cammarota; R Cianci; A Bianchi; E Sacco; L Tilaro; E Marzetti; M Certo; G Pirozzi; P Fedeli; F Pandolfi; A Pontecorvi; G Gasbarrini; L De Marinis
Journal:  Dig Dis Sci       Date:  2004-04       Impact factor: 3.199

10.  PPARgamma, PTEN, and the Fight against Cancer.

Authors:  Rosemary E Teresi; Kristin A Waite
Journal:  PPAR Res       Date:  2008-12-14       Impact factor: 4.964

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.